Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus

Archives of Internal Medicine

Volumn 162, Issue 19, 2002, Pages 2229-2235

  Blot, Stijn I ^a   Vandewoude, Koenraad H ^a   Hoste, Eric A ^a   Colardyn, Francis A ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN;

ACUTE KIDNEY FAILURE; ACUTE RESPIRATORY FAILURE; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CRITICAL ILLNESS; HUMAN; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS;

AGED; BACTEREMIA; CASE-CONTROL STUDIES; COHORT STUDIES; CROSS INFECTION; HUMANS; KIDNEY FAILURE, ACUTE; LENGTH OF STAY; METHICILLIN RESISTANCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE;

EID: 0037190693     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.19.2229     Document Type: Article

References (43)

1. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: Impact of intravascular devices and methicillin-resistance. Clin Infect Dis. 1996;23:255-259.
2. Cheng AFB, French GL. Methicillin-resistant Staphylococcus aureus bacteremia in Hong Kong. J Hosp Infect. 1988;12:91-101.
3. Lautenschlager S, Herzog C, Zimmerli W. Course and outcome of bacteremia due to Staphylococcus aureus: Evaluation of different clinical case defintions. Clin Infect Dis. 1993;16:567-573.
4. Gransden WR, Eykyn SJ, Phillips I. Staphylococcus aureus bacteremia; 400 episodes in St Thomas's Hospital. Br Med J (Clin Res Ed). 1984;288:300-303.
5. Cheong I, Samsudin LM, Law GH. Methicillin-resistant Staphylococcus aureus bacteremia at a tertiary teaching hospital. Br J Clin Pract. 1996;50:237-239.
6. Cafferkey MT, Hone R, Keane CT. Sources and outcome for methicillin-resistant Staphylococcus aureus bacteremia. J Hosp Infect 1988;11:136-143.
7. Yzerman E, Boelens H, Tjhie J, Kluytmans J, Mouton J, Verbrugh H. Delta APACHE II for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defense. J Infect Dis. 1996;173: 914-919.
8. Selvey L, Whitby M, Johnson B. Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: Is it any worsethan nosocomial methicillin-susceptible Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol. 2000;21:645-648.
9. Abramson MA, Bronstein MZ, Oden MA, et al. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what cost? Infect Control Hosp Epidemiol. 1999;20:408-411:
10. Knaus WA, Draper EA, Wagner DP, Zimmerman JE APACHE II: A severity of disease classification system. Crit Care Med. 1985;13:818-829.
11. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med. 2000; 162:1027-1030.
12. Girou E, Stephan F, Novara A, Safar M, Fagon J-Y. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med. 1998;157:1151-1158.
13. Rello J, Jupert P, Valles J, Artigas A, Rue M, Niederman M. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis. 1996;23:973-978.
14. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1993:14. NCCLS document M2A5.
15. Wenzel R. The mortality of hospital-acquired blood stream infections: Need for a new vital statistic? Int J Epidemiol. 1988;17:225-227.
16. Rello J, Ricart M, Mirelis B, et al. Nosocomial bacteremia in a medical-surgical intensive care unit: Epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med. 1994;20:94-98.
17. Lewis E, Saravolatz LD. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control. 1985;13:109-114.
18. Duckworth GJ, Jordens JZ. Adherence and survival properties of an epidemic methicillin-resistant strain of Staphylococcus aureus compared with those of methicillin-sensitive strains. J Med Microbiol. 1990;32:195-200.
19. Jordens JZ, Duckworth GJ, Williams RJ. Production of virulence factors by epidemic methicillin-resistant Staphylococcus aureus in vitro. J Med Microbiol. 1989; 30:245-252.
20. Boyce JM, Landry M, Deetz TR, Dupont ML. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect Control. 1981;2:110-116.
21. Crossley K, Landesman B, Zaske D. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides: 11 Epidemiologic studies. J Infect Dis. 1979;139:280-287.
22. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 1994;13:96-102.
23. Hershow RC, Hhayr WF, Smith NL. A comparison of clinical virulence of nosocomial acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol. 1992;13: 587-593.
24. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987;9:891-907.
25. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med. 1998;158:182-189.
26. Mylotte JM, Aeschlimann JR, Rotella DL. Staphylococcus aureus bacteremia: Factors predicting hospital mortality. Infect Control Hosp Epidemiol. 1996;17:165-168.
27. Romero-Vivas J, Rubio M, Fernandez C, Picazo J. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1995;21:1417-1423.
28. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 1998;19:32-37.
29. Soriano A, Martinez J, Mensa J, Anta M, Soriano E. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis. 2000;30:368-373.
30. DiGiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial blood stream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160:976-981.
31. French G, Cheng A, Ling J, Mo P, Donnan S. Hong Kong strains of methicillin-resistant and methicillin-susceptible Staphylococcus aureus have similar virulence. J Hosp Infect. 1990;15:117-125.
32. Pujol M, Pena C, Pallares R, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med. 1996;100:509-516.
33. McManus AT, Mason AD, McManus WF, Pruitt BA. What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin? Arch Surg. 1989;124:1456-1459.
34. Muder RR, Brennen C, Wagener MM. Methicillin-resistant staphylococcal colonization and infection in a long term care facility. Ann Intern Med. 1991;114: 107-112.
35. Archer G, Climo M. Staphylococcus aureus bacteremia - Consider the source. N Engl J Med. 2001;344:55-56.
36. Ward T. Comparison of the in vitro adherence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus to human nasal epithelial cells. J Infect Dis. 1992;166:400-404.
37. Waudaux O, Waldvogel F. Methicillin-resistant strains of Staphylococcus aureus: Relation between expression of resistance and phagocytosis by polymorphonuclear leucocytes. J Infect Dis. 1979;139:547-552.
38. Peacock J, Moorman D, Wenzel R, Mandell D. Methicillin-resistant Staphylococcus aureus: Microbiologic characteristics, antimicrobial susceptibilities and assessment of virulence of an epidemic strain. J Infect Dis. 1981;144:575-582.
39. Cutler R. Relationship between antibiotic resistance, the production of virulence factors, and virulence for experimental animals in Staphylococcus aureus. J Med Microbiol. 1979;12:55-62.
40. Schmitz F, Mackenzie C, Geisel R, et al. Enterotoxin and toxic shock syndrome toxin-1 production by methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains. Eur J Clin Microbiol. 1997;13:699-708.
41. Hewitt H, Sanderson P. The effect of methicillin on skin lesions of guinea pigs caused by "methicillin-sensitive" and "methicillin-resistant" Staphylococcusaureus. J Med Microbiol. 1974;7:223-228.
42. Gedney J, Lacey R. Properties of methicillin-resistant staphylococci now endemic in Australia. Med J Aust. 1982;4:448-450.
43. Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo J. Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis. 1999;29: 1171-1177.